The inhibition of NFKB1, which acts as a transcription factor in the SEC14L3 promoter and enhancer regions, further suppresses SEC14L3 expression, establishing a positive feedback loop of SEC14L3/RPS3/NFκB that collectively inhibits ccRCC progression. Here, NFKB1 is linked to nonpapillary renal cell carcinoma.